Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

June 2026 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In June 2026, FDA received 116,816 drug adverse event reports. In June 2025, FDA received 105,643.

In June 2026, FDA received 328,804 medical device reports. In June 2025, FDA received 247,453.

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

FDA received 110,107 drug reports a month on average in the 12 months before June 2026.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to June 2026
0100,000200,000202420252026

Drugs in the reports

The table has the 119 drug pages with 250 or more reports in June 2026. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of June 2026 name as a suspect product, in order of name
DrugReports in the month
Acetaminophen721
Acoltremon1,415
Actemra290
Acthar443
Adalimumab711
Adalimumab-aaty261
Adbry256
Aimovig285
Albuterol sulfate300
Amlodipine329
Apixaban252
Aripiprazole310
Aspirin259
Atorvastatin487
Bevacizumab464
Bimzelx578
Bortezomib345
Brinsupri590
Cabometyx501
Camzyos272
Carboplatin943
Cimzia477
Cisplatin377
Corticotropin788
Cosentyx493
Creon308
Cyclophosphamide1,083
Cyclosporine362
Cytarabine324
Dapagliflozin615
Depo-Provera513
Dexamethasone854
Diazepam324
Diclofenac sodium483
Docetaxel281
Doxorubicin428
Dupixent12,458
Eliquis542
Emgality290
Enbrel505
Enhertu293
Etoposide420
Evenity308
Fentanyl328
Filspari260
Fluorouracil448
Foundayo484
Gabapentin366
Genotropin349
Hemangeol416
Humira619
Hydrocortisone253
Ibuprofen473
Infliximab531
Infliximab-dyyb445
Jakafi354
Kevzara448
Keytruda671
Kisqali305
Lamotrigine292
Lantus735
Lenalidomide1,440
Levetiracetam297
Metformin456
Methotrexate980
Methylprednisolone293
Minoxidil281
Mirtazapine274
Mounjaro1,636
Mycophenolate mofetil780
Nemluvio786
Nivolumab350
Nucala262
Nuplazid785
Olanzapine343
Opdivo298
Orencia698
Osimertinib402
Otezla391
Oxaliplatin524
Oxycodone310
Oxycodone hydrochloride258
Ozempic1,428
Paclitaxel683
Pantoprazole261
Pembrolizumab574
Pomalidomide269
Prednisolone489
Prednisone1,216
Pregabalin419
Prolia524
Quetiapine298
Remicade289
Repatha1,306
Revlimid428
Rinvoq1,011
Rituximab1,299
Sertraline343
Simponi451
Skyrizi1,436
Spravato310
Stelara258
Tacrolimus781
Tavalisse1,016
Tislelizumab293
Trastuzumab273
Tremfya718
Trulicity346
Tymlos3,853
Ustekinumab264
Vabysmo294
Vevye601
Vincristine336
Wegovy2,075
Xolair337
Xphozah270
Yutrepia480
Zepbound3,033
Zepbound Kwikpen1,052

Reaction terms in the reports

The table has the 124 reaction terms with 500 or more reports in June 2026. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of June 2026 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort974
Abdominal distensiona bloated abdomen664
Abdominal painstomach or belly pain1,078
Abdominal pain upperupper stomach pain1,108
Accidental exposure to product1,521
Acute kidney injurysudden loss of kidney function940
Adverse drug reactiona harmful or unpleasant reaction (the term names a medicine)606
Alopeciahair loss847
Anaemialow red blood cells783
Anxietyanxiety1,122
Arthralgiajoint pain2,503
Astheniaweakness or lack of energy1,686
Asthmaasthma714
Back painback pain1,078
Blood glucose increasedraised blood sugar reading601
Blood pressure increaseda raised blood pressure reading710
Bone painbone pain524
Cerebrovascular accidentstroke598
Chest discomfortchest discomfort610
Chest painchest pain731
Condition aggravatedthe condition being treated got worse1,778
Confusional stateconfusion672
Constipationconstipation1,435
Coughcough1,556
Deaththe patient died; cause not stated by this term4,011
Decreased appetitereduced appetite1,188
Dehydrationdehydration611
Depressionlow mood656
Dermatitis atopic1,033
Device issuea problem with the device723
Device malfunctionthe device did not work properly861
Diarrhoealoose or frequent stools3,906
Disease progressionthe disease advanced674
Dizzinesslight-headedness or unsteadiness2,928
Drug dose omission by device780
Drug hypersensitivityan allergic-type reaction (the term names a medicine)622
Drug ineffectivethe medicine did not work as expected6,293
Drug interactionan interaction between medicines975
Drug intolerancethe medicine was not tolerated518
Dry eyedry eye682
Dry skindry skin1,040
Dyspepsiaindigestion564
Dyspnoeashortness of breath2,477
Eczemaeczema783
Erythemaskin redness939
Exposure via skin contact1,202
Eye irritationeye irritation1,270
Eye paineye pain510
Falla fall1,476
Fatiguetiredness4,254
Feeling abnormalfeeling odd or not right913
Gait disturbancedifficulty walking675
Gastrointestinal disorder783
General physical health deteriorationgeneral decline in health710
Headachehead pain3,495
Heart rate increaseda fast heart rate reading748
Hospitalisationadmission to hospital1,128
Hyperhidrosisexcessive sweating504
Hypersensitivityan allergic-type reaction898
Hypertensionhigh blood pressure960
Hypoaesthesianumbness547
Hypotensionlow blood pressure1,086
Illness1,272
Inappropriate schedule of product administrationthe product was taken at the wrong times1,634
Incorrect dose administeredthe wrong dose was given1,703
Infectionan infection, type not specified715
Injection site bruisingbruising where the injection was given766
Injection site erythemaredness where the injection was given762
Injection site haemorrhagebleeding where the injection was given527
Injection site painpain where the injection was given2,418
Injection site swellingswelling where the injection was given552
Insomniadifficulty sleeping1,057
Joint swellinga swollen joint649
Malaisegeneral feeling of being unwell1,626
Malignant neoplasm progression779
Maternal exposure during pregnancythe mother took the medicine during pregnancy652
Memory impairmentmemory problems514
Migrainemigraine667
Muscle spasmsmuscle cramps838
Muscular weaknessmuscle weakness534
Myalgiamuscle pain797
Myelosuppression763
Nasopharyngitisa cold725
Nauseafeeling sick4,682
Neuropathy peripheralnerve damage in hands or feet698
Neutropenialow neutrophils, a type of white blood cell776
No adverse eventno adverse event was reported1,115
Off label useused for a purpose or in a way not on the label6,148
Overdosea dose above the recommended amount547
Painpain, site not specified2,294
Pain in extremitypain in an arm or leg1,081
Palpitationsawareness of the heartbeat899
Paraesthesiatingling or pins and needles641
Peripheral swellingswelling of the arms or legs862
Platelet count decreasedlow platelet count592
Pneumonialung infection1,641
Product dose omission in error504
Product dose omission issuea dose was missed3,846
Product prescribing issue535
Product storage errorthe product was stored wrongly609
Product use in unapproved indicationused for a purpose not on the label2,197
Product use issuea problem in how the product was used1,227
Pruritusitching3,285
Pyrexiafever1,438
Rashskin rash2,478
Rheumatoid arthritisrheumatoid arthritis, an inflammatory joint disease502
Seizurea fit or convulsion603
Sepsisa severe body-wide response to infection503
Skin exfoliationpeeling skin615
Sleep disordera sleep problem506
Somnolencedrowsiness1,039
Therapy interrupted900
Thrombocytopenialow platelets605
Toxicity to various agentspoisoning or toxic effect of one or more substances831
Treatment failurethe treatment did not work563
Tremorshaking655
Urinary tract infectionbladder or urinary infection802
Urticariahives1,057
Vision blurredblurred vision734
Visual impairmentreduced vision797
Vomitingbeing sick2,600
Weight decreasedweight loss1,091
Weight increasedweight gain1,324
Wrong technique in product usage processthe product was used in the wrong way898

Devices in the reports

The table has the 61 device pages with 500 or more reports in June 2026. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of June 2026 name, in order of name
Brand nameReports in the month
Alaris System2,709
BD Pyxis Anesthesia Station ES501
BD Pyxis ES Server525
BD Pyxis MedStation ES3,083
BD Pyxis MedStation ES Auxiliary956
BioHorizons Inc.2,887
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim846
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim783
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP663
BLT ?4.8mm RC, SLA? 10mm, Ti, Loxim566
BLT ?4.8mm RC, SLA? 8mm, Ti, Loxim657
CapSureFix Novus Lead MRI SureScan1,545
CareLink SmartSync Common App iOS7,354
Colonovideoscope505
Contact Detach860
daVinci Xi631
Dexcom G6 Continuous Glucose Monitoring System4,298
Dexcom G7 15 Day Continuous Glucose Monitoring System2,463
Dexcom G7 Continuous Glucose Monitoring System16,706
DreamStation Auto CPAP8,186
DreamStation Expert653
Endowrist2,239
Evis Lucera Elite Colonovideoscope874
Evis Lucera Elite Gastrointestinal Videoscope918
FreeStyle Libre 21,908
FreeStyle Libre 2 Plus4,228
FreeStyle Libre 326,732
FreeStyle Libre 3 Plus13,190
Gastrointestinal Videoscope716
iLet Bionic Pancreas4,254
Impella1,689
Inset3,792
Inset 30534
Inset Guard6,712
Inspira Smooth Silicone Gel Filled Breast Implant658
Ivenix Infusion System511
LifeVest WCD 4000 System845
Medline1,696
MENTOR MemoryGel Breast Implant634
Midas Rex MR81,933
MiniMed 780G OUS System BLE Connect 3.0 mmol/L1,667
MiniMed 780G US System BLE Connect 3.0 mg/dL4,365
NobelActive Internal RP 4.3x10mm828
NobelParallel CC RP 4.3x10mm918
NobelParallel CC RP 4.3x8.5mm502
NobelReplace CC PMC RP 4.3x10mm746
NobelReplace CC PMC RP 4.3x8mm537
NobelReplace CC RP 4.3x10mm632
Omnipod 5 Automated Insulin Delivery System2,901
Omnipod 5 Pod1,502
Omnipod 5 Pods3,908
Other Accessories2,779
Pump 1886 780G OUS BLE Pump mg/dL3,264
PUMP MMT-1884L MM780G BLE 3.0 mg/ml603
Quick Set4,308
Sprint Quattro Secure S MRI SureScan550
t:slim X2 Insulin Pump with Control-IQ Technology10,321
t:slim X2 Insulin Pump with Control-IQ+ Technology5,328
t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)941
Tandem Mobi Insulin Pump with Control-IQ+ Technology2,641
Transmitter Mmt-7841zw Gst5g Ous843

Cite this page

Reported Reactions. June 2026: adverse event reports received by FDA. https://reportedreactions.com/month/2026-06/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for June 2026 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 116,816 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.